Impact of Non Surgical Periodontal Therapy on Cystatin C Levels
NCT ID: NCT07103421
Last Updated: 2025-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2023-05-12
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Periostin and Non-Surgical Periodontal Treatment
NCT04332965
Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus
NCT07256613
Analysis of the Impact of Contemporary Subgingival Debridement Techniques on Immunological Biomarkers in Gingival Crevicular Fluid
NCT07243145
Bactericidal Permeability Protein Inhibitor and Interleukin-1beta Levels After Non-surgical Periodontal Treatment
NCT06354504
Changes in Periodontal Pocket Depth After Periodontal Treatment
NCT07327658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy controls
10 systemically and periodontally healthy patients who will not receive any periodontal treatment. Cystatin C levels will be measured at baseline.
No interventions assigned to this group
Periodontitis patients
10 patients with periodontitis but no systemic diseases who will receive Non-Surgical Periodontal Therapy (scaling and root plannong). Cystatin C levels will be measured before and after treatment.
Non-Surgical Periodontal Therapy
Non-surgical periodontal therapy involves the removal of bacterial plaque and calculus from tooth surfaces and root surfaces beneath the gum line using manual or ultrasonic instruments. This treatment is performed for patients with periodontitis to improve gum health and reduce inflammation. Serum cystatin C levels will be compared before and after treatment between healthy patients and those with renal impairment.
Periodontitis with CKD
10 patients with periodontitis and 1-3 chronic kidney disease who will receive non-surgical periodontal therapy. Cystatin C levels and renal function will be monitored.
Non-Surgical Periodontal Therapy
Non-surgical periodontal therapy involves the removal of bacterial plaque and calculus from tooth surfaces and root surfaces beneath the gum line using manual or ultrasonic instruments. This treatment is performed for patients with periodontitis to improve gum health and reduce inflammation. Serum cystatin C levels will be compared before and after treatment between healthy patients and those with renal impairment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Surgical Periodontal Therapy
Non-surgical periodontal therapy involves the removal of bacterial plaque and calculus from tooth surfaces and root surfaces beneath the gum line using manual or ultrasonic instruments. This treatment is performed for patients with periodontitis to improve gum health and reduce inflammation. Serum cystatin C levels will be compared before and after treatment between healthy patients and those with renal impairment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age range: 20 to 70 years.
* No pathological tooth mobility.
* No furcation involvement caused by periodontal disease.
* No systemic diseases affecting periodontal or renal health.
* No systemic antibiotic use within the previous 3 months.
* No periodontal treatment within the previous 6 months
For Chronic Kidney Disease (CKD) Patients:
* Confirmed CKD diagnosis for at least 3 years (by a consultant nephrologist).
* Receiving conservative management (pre-dialysis).
Exclusion Criteria
* Grade C periodontal disease.
* Bone loss in more than 10 sites.
* Pathological tooth mobility (Grade II or III).
* Furcation involvement due to periodontal disease.
* Tooth loss due to periodontal disease.
* Heavy smoking (\>10 cigarettes/day).
* Pregnancy or lactation.
* Patients undergoing dialysis.
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tishreen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hashm Daoud, Prof
Role: STUDY_CHAIR
Tishreen University, faculty of Dentistry
Nebras Naddaf, Phd's student
Role: PRINCIPAL_INVESTIGATOR
Tishreen University, faculty of Dentistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tishreen University - faculty of Dentistry
Latakia, , Syria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tishreen U _ periodontic
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.